메뉴 건너뛰기




Volumn 42, Issue 9, 2001, Pages 1359-1363

Alendronate does not interfere with 99mTc-methylene diphosphonate bone scanning

Author keywords

99mTc methylene diphosphonate; Bisphosphonate; Bone metastasis; Prostate

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; MEDRONATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

EID: 0034741790     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (19)

References (20)
  • 3
    • 0030565675 scopus 로고    scopus 로고
    • Metastatic bone disease and the role of bisphosphonates: Special report
    • (1996) Br J Hosp Med , vol.56 , pp. 339-345
    • Ellis, M.J.C.1
  • 5
    • 0029782630 scopus 로고    scopus 로고
    • Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: Results from a multinational randomized controlled trial
    • (1996) J Clin Oncol , vol.14 , pp. 2552-2559
    • Conte, P.F.1    Latreille, J.2    Mauriac, L.3
  • 16
    • 0019513723 scopus 로고
    • Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat
    • (1981) Br J Radiol , vol.54 , pp. 592-596
    • Watt, I.1    Hill, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.